Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2024
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)Tiuri E Kroese, Sebastiaan Bronzwaer, Peter S N van Rossum, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Ebiomedicine|July 22, 2023
Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer"Timo Hess, Carlo Maj, Jan Gehlen, et al.
Ebiomedicine|May 20, 2023
Dissecting the genetic heterogeneity of gastric cancerTimo Hess, Carlo Maj, Jan Gehlen, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
Lancet (London, England)|April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialSalah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2024
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)Tiuri E Kroese, Sebastiaan Bronzwaer, Peter S N van Rossum, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Ebiomedicine|July 22, 2023
Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer"Timo Hess, Carlo Maj, Jan Gehlen, et al.
Ebiomedicine|May 20, 2023
Dissecting the genetic heterogeneity of gastric cancerTimo Hess, Carlo Maj, Jan Gehlen, et al.
Pageof 22